(CBPO) With Shares Trading unchanged at $97.15 China Biologic Agrees to Acquire…

Lloyd Doyle
October 13, 2017

It operates as an exchange traded products sponsor and asset manager providing investment advisory services in the United States, Europe, Canada and Japan. The CFDA completed on-site inspection of Shandong Taibang's production facility in late 2016 and completed on-site clinical data inspection at various hospitals that carried out the phase III clinical trials during the second quarter of 2017. The stock of China Biologic Products Holdings, Inc. Autodesk Inc. had 89 analyst reports since August 4, 2015 according to SRatingsIntel.

Pl Capital Advisors Llc holds 8.57% of its portfolio in First Merchants Corporation for 811,333 shares. The Oberweis Asset Management Inc holds 3,000 shares with $339,000 value, down from 35,385 last quarter. Jennison Assoc Ltd Limited Liability Company owns 5,775 shares. Its down 0.37, from 1.02 in 2017Q1. This company shares are 28.45% off its target price of $124.79 and the current market capitalization stands at $2.67B. (NASDAQ:CBPO) has declined 1.48% since October 12, 2016 and is downtrending. Illinois-based Blair William & Co Il has invested 0.01% in Autodesk, Inc.

Since May 8, 2017, it had 0 insider purchases, and 1 sale for $873,638 activity. York Cap Management Ltd Liability Corp owns 80,229 shares for 0.19% of their portfolio. Frontier Capital Management Co Llc, a Massachusetts-based fund reported 1.03 million shares. Finally, Zacks Investment Research downgraded China Biologic Products from a "hold" rating to a "sell" rating in a research report on Monday, August 7th. Given that its average daily volume over the 30 days has been 1.03 million shares a day, this signifies a pretty significant change over the norm. Axa invested in 0.05% or 94,334 shares.

Investors sentiment decreased to 0.65 in 2017 Q2. It worsened, as 27 investors sold CBPO shares while 42 reduced holdings. (NASDAQ:CBPO)'s stock about -14.11% from the 50-day high and -2.46% away from the 50-day low. Hutchin Hill Cap Lp reported 2,900 shares stake. (NASDAQ:CBPO). Nordea Inv Mngmt Ab holds 0% in China Biologic Products Holdings, Inc. 11 funds opened positions while 34 raised stakes. (NASDAQ:CBPO) or 2.07M shares.


About 106,386 shares traded. Zacks has also given China Biologic Products an industry rank of 159 out of 265 based on the ratings given to related companies. (NASDAQ:CBPO) for 63,620 shares. The firm has "Sector Perform" rating given on Friday, November 20 by RBC Capital Markets.

Analysts await China Biologic Products Holdings, Inc. First Tru Advisors L P invested in 0% or 16,173 shares.

Among 2 analysts covering China Biologic Products (NASDAQ:CBPO), 2 have Buy rating, 0 Sell and 0 Hold. Moreover, Federated Invsts Pa has 0% invested in Federated National Holding Co (NASDAQ:FNHC) for 2,329 shares. The firm earned "Buy" rating on Friday, September 4 by Jefferies. Smithfield Trust Co holds 0.01% or 499 shares in its portfolio. (NASDAQ:CBPO) to report $1.30 EPS on November, 1.They anticipate $0.29 EPS change or 28.71% from last quarter's $1.01 EPS. In the latest earnings report the EPS was $3.84 and is estimated to be $4.95 for the current year with 27,238,000 shares now outstanding. CBPO's profit will be $36.29M for 18.74 P/E if the $1.30 EPS becomes a reality. (NASDAQ:CBPO). Ameriprise Finance Incorporated stated it has 0.01% of its portfolio in China Biologic Products Holdings, Inc.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER